Back to the list

Douglas Hansen-Luke

Executive Chairman

Future Planet Capital

Douglas is the Executive Chairman and Founder of Future Planet Capital. He leads the Future Planet flagship fund and the British Innovation Fund. He also spearheaded FPC’s investment and a $100M+ syndicate investment into Barinthus Bio (formerly Vaccitech), theOxford spinout responsible for the Oxford-AstraZeneca COVID-19 vaccine, which successfully administered 2bn doses. Additionally, Douglas has led investments into Pragmatic, NeoVac, Nutri-San, and chairs the global growth strategies investment committees at FPC.

 

 He spent nearly 20 years living or working in emerging markets and has been involved in the deployment and marketing of over $13bn, predominantly in new assets classes. He has extensive experience working in Eastern Europe, Africa and Asia via his work at Robeco (CEO for ME, Africa & Central Asia), bfinance (Board Advisor and CEO for ME, Africa and Central Asia), ABN AMRO Asset Management (Far East, Global & Regional leadership positions) and Bain & Company (Eastern European 1990s Privatisation).

 

Douglas has been a thought leader in this space, having frequently wrote and advised the world's largest institutional investors on investing in commodities within emerging markets, including book chapters for the Financial Times along with speaker slots on Bloomberg, the BBC and CNBC. He sits on the Advisory Board of the Rwandan Cricket Stadium Fund, on the Jesus College (Oxford), Campaign Board and on the Committee of the Poppy Ball.